Elliott Vichinsky, MD: Voxelotor and New HOPE Data
The UCSF hematologist discusses the growing portfolio for the sickle cell therapy after ASH 2020.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.
The UCSF hematologist discusses the growing portfolio for the sickle cell therapy after ASH 2020.
The skinny isn't ready yet — notes appear once the transcript is processed.